Top Markets
Coin of the day
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Kedudukan dalam Saham #5577
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Harga Saham
$36.98
Disegerakkan terakhir: 2026-08-26
Modal Pasaran
$2.58B
Perubahan (1 hari)
-0.67%
Perubahan (1 tahun)
55.51%
Negara
NL
Perdagangan Pharvaris N.V. (PHVS)

Kategori

Sejarah pecahan saham untuk Pharvaris N.V. (PHVS)
Saham Pharvaris N.V. (simbol: PHVS) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 27, 2026.
Satu saham PHVS yang dibeli sebelum Aug 27, 2026 kini bersamaan dengan 0 saham PHVS.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH